{"title":"Social determinants of health in cancer survivors and the risk of cardiovascular events.","authors":"Shunxuan Yan, Yingsi Hu, Weiwen Su, Shangxi Xie, Jialing Lin, Jinfeng Ding, Jinqiu Yuan, Jiali Feng, Qiangsheng He, Da-Lin Lu, Yanhui Gao, Xiwen Qin","doi":"10.1093/eurjpc/zwaf633","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>The impact of social determinants of health (SDoH) on cardiovascular disease (CVD) risk in cancer survivors remains unclear. We examined the association between SDoH and subsequent CVD risk among cancer survivors.</p><p><strong>Methods: </strong>This retrospective cohort study included 18,992 cancer survivors and 75,968 propensity score-matched non-cancer controls from the UK Biobank. A composite SDoH score was generated using 17 components across 5 domains, classifying participants into favorable, medium, and unfavorable SDoH groups. Cox models were used to assess associations between SDoH and incident CVD, including ischemic heart disease (IHD), heart failure (HF), stroke, and CVD mortality.</p><p><strong>Results: </strong>Compared with cancer survivors with favorable SDoH, those with medium and unfavorable SDoH had higher CVD risks: hazard ratio (HR) 1.17 (95% CI: 1.09-1.27) and HR 1.32 (95% CI: 1.23-1.43), respectively. Unfavorable SDoH was also associated with increased risk of IHD (HR: 1.31; 95% CI: 1.15-1.49), HF (HR: 1.58; 95% CI: 1.30-1.92), stroke (HR: 1.47; 95% CI: 1.18-1.84), and CVD mortality (HR: 1.54; 95% CI: 1.25-1.90). Cancer survivors with favorable SDoH had overall CVD risks similar to matched non-cancer controls (HR: 1.07; 95% CI: 1.00-1.13). In joint analysis, cancer survivors with favorable SDoH had a higher risk (HR: 1.22; 95% CI, 1.15-1.28) than their non-cancer counterparts.</p><p><strong>Conclusion: </strong>Among cancer survivors, unfavorable SDoH were associated with elevated CVD risk, whereas favorable SDoH attenuated this risk to levels comparable with non-cancer population. That may partly reflect the increased risk observed among non-cancer with unfavorable SDoH. Targeted interventions and policy measures addressing social determinants are needed to mitigate cardiovascular disparities in cancer survivorship.</p>","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of preventive cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurjpc/zwaf633","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: The impact of social determinants of health (SDoH) on cardiovascular disease (CVD) risk in cancer survivors remains unclear. We examined the association between SDoH and subsequent CVD risk among cancer survivors.
Methods: This retrospective cohort study included 18,992 cancer survivors and 75,968 propensity score-matched non-cancer controls from the UK Biobank. A composite SDoH score was generated using 17 components across 5 domains, classifying participants into favorable, medium, and unfavorable SDoH groups. Cox models were used to assess associations between SDoH and incident CVD, including ischemic heart disease (IHD), heart failure (HF), stroke, and CVD mortality.
Results: Compared with cancer survivors with favorable SDoH, those with medium and unfavorable SDoH had higher CVD risks: hazard ratio (HR) 1.17 (95% CI: 1.09-1.27) and HR 1.32 (95% CI: 1.23-1.43), respectively. Unfavorable SDoH was also associated with increased risk of IHD (HR: 1.31; 95% CI: 1.15-1.49), HF (HR: 1.58; 95% CI: 1.30-1.92), stroke (HR: 1.47; 95% CI: 1.18-1.84), and CVD mortality (HR: 1.54; 95% CI: 1.25-1.90). Cancer survivors with favorable SDoH had overall CVD risks similar to matched non-cancer controls (HR: 1.07; 95% CI: 1.00-1.13). In joint analysis, cancer survivors with favorable SDoH had a higher risk (HR: 1.22; 95% CI, 1.15-1.28) than their non-cancer counterparts.
Conclusion: Among cancer survivors, unfavorable SDoH were associated with elevated CVD risk, whereas favorable SDoH attenuated this risk to levels comparable with non-cancer population. That may partly reflect the increased risk observed among non-cancer with unfavorable SDoH. Targeted interventions and policy measures addressing social determinants are needed to mitigate cardiovascular disparities in cancer survivorship.
期刊介绍:
European Journal of Preventive Cardiology (EJPC) is an official journal of the European Society of Cardiology (ESC) and the European Association of Preventive Cardiology (EAPC). The journal covers a wide range of scientific, clinical, and public health disciplines related to cardiovascular disease prevention, risk factor management, cardiovascular rehabilitation, population science and public health, and exercise physiology. The categories covered by the journal include classical risk factors and treatment, lifestyle risk factors, non-modifiable cardiovascular risk factors, cardiovascular conditions, concomitant pathological conditions, sport cardiology, diagnostic tests, care settings, epidemiology, pharmacology and pharmacotherapy, machine learning, and artificial intelligence.